204. HER2-Specific Chimeric Antigen Receptor T Cells for the Treatment of Breast-To-Brain Metastasis
Molecular Therapy - United States
doi 10.1016/s1525-0016(16)33013-1
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2016
Authors
Publisher
Elsevier BV